WATSON 152 8 mg (Rapaflo 8 mg)
Generic Name: silodosin
Pill imprint WATSON 152 8 mg has been identified as Rapaflo 8 mg.
Rapaflo is used in the treatment of benign prostatic hyperplasia and belongs to the drug class antiadrenergic agents, peripherally acting. There is no proven risk in humans during pregnancy. Rapaflo 8 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WATSON 152 8 mg (Rapaflo 8 mg)
Rapaflo
- Generic Name:
- silodosin
- Imprint:
-
WATSON 152
8 mg - Strength:
- 8 mg
- Color:
- White
- Size:
- 19.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antiadrenergic agents, peripherally acting
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 52544-0152
More resources
Rapaflo is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
